✨ 6 results found - Searched 23749 records in 1ms.
Tesis
Nilai Prognostik Ekspresi p16 dan Kadar CA19-9 Terhadap Kesintasan Bebas Penyakit pada Pasien Adenokarsinoma Duktal Pankreas Pascareseksi
2026 | BY Rizky Dwi Kurnia Robby Anwar - Nur Rahadiani - Agi Satria Putranto - Vania Myralda Giamour Marbun- Prognostic Value of p16 Expression and CA19-9 Levels on Disease-Free Survival in Patients with Postresection Pancreatic Ductal Adenocarcinoma.
- Nomor Panggil T26277fk
Tesis
Faktor – Faktor Yang Berhubungan Dengan Kesintasan 6 Bulan Pasien Adenokarsinoma Pankreas Stadium IV di Rumah Sakit Cipto Mangunkusumo Tahun 2019-2024
2026 | BY Wulyo Rajapto - Arif Mansjoer - Hasan Maulahela - Dian Wienarni Erwin- Prognostic Factors Associated with 6-Month Survival in Patients with Stage IV Pancreatic Adenocarcinoma, A Retrospective Cohort Study at Cipto Mangunkusumo Hospital, 2019–2024.
- Nomor Panggil T26229fk
Tesis
Hubungan CA 19-9 Praoperasi Terhadap Resektabilitas Adenokarsinoma Kaput Pankreas
2020 | BY Pasihulizan - Agi Satria Putranto- Correlation Between Preoperative CA 19-9 Level with Pancreatic Adenocarcinoma Resectability.
- Nomor Panggil T20462fk
Tesis
Profil Ekspresi pVHL (von Hippel-Lindau Gene Product) pada Adenokarsinoma Duktal Pankreas dan Pankreas Non-Neoplastik serta Hubungannya dengan Profil Klinikopatologi
2023 | BY Jessica Prisscila - Marini Stephanie - Nur Rahadiani- Expression Profile of pVHL (von Hippel-Lindau Gene Product) in Pancreatic Ductal Adenocarcinoma and Non-Neoplastic Pancreas and Its Relationship with Clinicopathological Factors.
- Nomor Panggil T23450fk
Tesis
Ekspresi Imunohistokimia DPC4 Adenokarsinoma Pankreas pada Sampel Fine Needle Aspiration Biopsy (FNAB)
2019 | BY Mirna Albertina Wijaja - RAHMIATI - Kusmardi- DPC4 immunohistochemistry expression on Fine Needle Aspiration Biopsy (FNAB) of Adenocarcinoma pancreas.
- Nomor Panggil T19161fk
Tesis
Peran SMAD4 sebagai Bagian dari Panel Imunohistokimia untuk Membedakan Adenokarsinoma Duktal Pankreas dan Adenokarsinoma Ampula Vateri serta Hubungannya dengan Faktor Prognostik Histopatologi yang Lebih Agresif
2022 | BY Marini Stephanie - Nur Rahadiani - Diah Rini Handjari - Meike Pramono- The Role of SMAD4 as part of Immunohistochemical Panel to Differentiate Pancreatic Adenocarcinoma and Ampullary Adenocarcinoma and to Predict a More Aggressive Histopathological Prognostic Factors.
- Nomor Panggil T22150fk